CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income	$ 2,965,338	$ 2,390,251
Adjustments to reconcile net income to cash provided by operating activities
Stock based compensation expense	150,514	163,269
Depreciation and amortization	1,830,689	1,634,547
Loss (gain) on sale of assets	(1,424)	0
Bad debt and reduction in allowance for bad debt	16,715	23,925
(Decrease) increase in fair value of derivative warrant liability	1,780,203	(1,698,747)
(Gain) loss on commodity derivative contracts	721,531	(4,427,782)
Net cash settlements on commodity derivatives	(1,306,344)	4,507,370
Amortization of debt discount and deferred costs	0	47,826
Changes in operating assets and liabilities, net of effect of acquisition
Accounts receivable	(1,873,520)	2,260,654
Inventory	(2,540,005)	2,112,459
Prepaid expenses	800,702	1,061,222
Accounts payable	(166,427)	(1,603,145)
Accrued expenses	(190,676)	(3,269,590)
Other assets	1,800	(87,251)
Net cash provided by operating activities	2,189,096	3,115,008
Cash flows from investing activities
Internally developed software	0	(49,229)
Purchase of fixed assets	(1,018,979)	(442,180)
Proceeds from sale of fixed assets	1,600	0
Net cash used in investing activities	(1,017,379)	(491,409)
Cash flows from financing activities
Payments on finance leases	(122,052)	(53,119)
Proceeds from exercise of stock warrants	1,652,022	0
Contributions received from redeemable noncontrolling interest	0	21,000,000
Line of credit (payments) proceeds, net	(133,446)	(3,276,230)
Payments on note payable	(1,036,581)	(8,098,879)
Net cash provided by financing activities	359,943	9,571,772
Net change in cash, cash equivalents and restricted cash	1,531,660	12,195,371
Cash, cash equivalents, and restricted cash at beginning of the period	10,995,169	4,199,825
Cash, cash equivalents, and restricted cash at end of period	12,526,829	16,395,196
SUPPLEMENTAL INFORMATION
Cash paid for interest	236,677	352,806
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Exchanges of Series B Preferred Stock into common stock	4,397,236	0
Accretion of discount on Series B and B1 Preferred Stock	223,727	932,003
Dividends-in-kind accrued on Series B and B1 Preferred Stock	(258,138)	344,499
Initial adjustment of carrying amount redeemable noncontrolling interests	0	9,091,068
Accretion of redeemable noncontrolling interest to redemption value	373,748	10,966,349
Series B Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B and B1 Preferred Stock into Common Stock	1,978,494	0
Dividends-in-kind accrued on Series B and B1 Preferred Stock	157,778
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B and B1 Preferred Stock into Common Stock	3,256,024	$ 3,368,474
Dividends-in-kind accrued on Series B and B1 Preferred Stock	$ 214,405